Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNuGen Medical Devices Inc

NuGen Medical Devices Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.015 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
6.81M

Momentum Score

…

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.09
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

NuGen Medical Devices Inc appears to be a Canada-listed medical device company with limited public disclosures about its products or commercial stage. Its long-term growth may depend on successful product development, regulatory approvals and commercial adoption, and investors may find exposure to healthcare innovation and potential upside if technologies reach market.
Key risks include limited public information, early-stage development and likely need for additional financing, regulatory and clinical trial uncertainty, thin trading liquidity and execution risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.59M
Revenue Per Share
0.00
Gross Profit TTM
0.32M
Debt / Equity
-
ROE
-1472.02%
Net Debt
10.86M
ROCE
-44.62%
Diluted EPS TTM
-

Insight Announcement

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -5.22M -9.33M -5.57M -7.10M -3.66M
Net income -5.23M -9.36M -5.58M -7.11M -3.67M
Selling general administrative 5.03M 7.52M 4.24M 7.76M 2.65M
Gross profit 0.52M 0.16M 0.10M 0.09M 0.03M
Reconciled depreciation 0.65M 0.69M 0.65M 0.79M 0.40M
Ebit - - - -5.79M -2.59M
Ebitda - - - -5.09M -2.59M
Operating income -5.16M -8.04M -4.79M -7.67M -2.61M
Interest expense 1.67M 1.24M 1.01M 1.22M 0.67M
Tax provision 0.01M 0.03M 0.00M 0.00M 0.01M
Interest income - - - 0.02M 0.02M
Net interest income -1.85M -1.24M -0.86M -1.20M -0.89M
Income tax expense - - - - 0.01M
Total revenue 1.01M 0.33M 0.15M 0.14M 0.05M
Total operating expenses 6.17M 8.37M 4.94M 7.81M 2.66M
Cost of revenue 0.49M 0.17M 0.05M 0.05M 0.01M
Total other income expense net 1.79M -0.05M 0.07M 1.76M -0.16M
Net income from continuing ops -5.23M -9.36M -5.58M -7.11M -3.67M
Net income applicable to common shares - - - - -3.67M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 12.89M 6.95M 6.85M 8.84M 14.56M
Intangible assets 3.36M 3.89M 4.45M 5.02M 6.26M
Other current assets - - - - 6.01M
Total liab 18.57M 9.01M 9.11M 7.19M 15.25M
Total stockholder equity -5.67M -2.06M -2.26M 1.66M -0.69M
Other current liab - - - 0.01M 6.01M
Common stock - - - - 6.81M
Capital stock 23.22M 21.36M 15.07M 14.19M 6.81M
Retained earnings -34.37M -29.30M -20.61M -15.81M -8.70M
Other liab - - - - 0.92M
Good will 1.73M 1.69M 1.67M 1.67M 1.81M
Cash 6.95M 0.46M 0.13M 1.75M 0.27M
Total current liabilities 1.34M 3.29M 1.73M 1.23M 9.75M
Net debt 10.86M 7.39M 7.11M 4.18M 7.22M
Short long term debt 0.57M 2.14M 0.08M 0.33M 2.91M
Other stockholder equity - - - - 1.20M
Property plant equipment - - - - 0.03M
Total current assets 7.80M 1.33M 0.57M 2.15M 6.47M
Net tangible assets - - - - -8.76M
Net receivables 0.10M 0.02M 0.01M 0.01M 0.15M
Long term debt 17.23M 5.72M 7.16M 5.61M 4.58M
Inventory 0.32M 0.21M 0.08M 0.01M 0.01M
Accounts payable 0.67M 0.97M 1.44M 0.88M 0.82M
Non current assets total 5.09M 5.62M 6.28M 6.70M 8.09M
Capital lease obligations 0.00M 0.03M 0.16M - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.01M -0.05M -0.00M 0.00M 0.05M
Change to liabilities - - - 0.00M 0.44M
Total cashflows from investing activities - - - - 0.05M
Net borrowings 9.97M 5.71M -0.08M 0.07M 0.73M
Total cash from financing activities 11.21M 7.10M 4.85M 5.58M 1.62M
Change to operating activities - - - - 0.10M
Net income -5.23M -9.36M -5.58M -7.11M -3.67M
Change in cash 6.48M 0.33M -0.00M 1.47M 0.27M
Begin period cash flow 0.46M 0.13M 0.20M 0.28M 0.00M
End period cash flow 6.95M 0.46M 0.16M 1.75M 0.28M
Total cash from operating activities -4.71M -6.71M -4.88M -4.10M -1.39M
Issuance of capital stock - 6.58M 4.87M 5.51M 0.65M
Depreciation 0.65M 0.69M 0.73M 0.63M 0.38M
Change to inventory -0.11M -0.13M -0.01M -0.00M 0.00M
Change to account receivables - - - - 0.01M
Change to netincome - - - 2.61M 1.24M
Capital expenditures 0.01M 0.00M 0.00M 0.00M 0.01M
Change in working capital -0.34M -0.73M -1.73M -0.23M 0.66M
Stock based compensation 0.09M 1.36M 1.59M 1.31M 0.00M
Other non cash items 2.15M 1.23M 2.25M 1.15M 1.21M
Free cash flow -4.72M -6.72M -4.89M -4.10M -1.40M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NGMD
NuGen Medical Devices Inc		 -
-%		 0.01 - - 11.56 9.71 35.35 14.65
TLT
Theralase Technologies Inc.		 0.01
2.78%		 0.18 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.		 -0.01
4.55%		 0.10 - - 66.65 - 95.30 -
PINK
Perimeter Medical Imaging AI Inc		 -
-%		 0.18 4.13 - 18.78 11.34 20.22 -2.55
CHER
Cheelcare Inc.		 -
-%		 1.25 - - 20.92 106.42 21.26 -

Profile*

NuGen Medical Devices Inc

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.

18 King Street East, Toronto, ON, Canada, M5C 1C4

833 285 2666

https://www.nugenmd.com

Name Title Year Born
Mr. Michael Wright Pres, CEO & Director 1967
Ms. Veronique Laberge CFO & Sec. 1983
Mr. Nicky Canton Chief Operating Officer 1983
Ms. Elisha Dillon Head of Global Sales & Strategic Partnerships NA
Mr. Anthony Di Benedetto Executive Chairman 1972
Mr. Ian Heynen Chief Executive Officer NA
Mr. Richard Buzbuzian BA President & Director 1971
Ms. Veronique Laberge B.A., CPA CFO & Secretary 1983
Mr. Nicky Canton Executive VP & COO 1984
Ms. Karen Dunlap Interim Chief Customer Officer & Director 1948

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…